These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19875972)

  • 1. Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas.
    Toh CK; Ahmad B; Soong R; Chuah KL; Tan SH; Hee SW; Leong SS; Tan EH; Lim WT
    J Thorac Oncol; 2010 Jan; 5(1):17-22. PubMed ID: 19875972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificities of lung adenocarcinoma in women who have never smoked.
    Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
    J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.
    Kato Y; Peled N; Wynes MW; Yoshida K; Pardo M; Mascaux C; Ohira T; Tsuboi M; Matsubayashi J; Nagao T; Ikeda N; Hirsch FR
    J Thorac Oncol; 2010 Oct; 5(10):1551-8. PubMed ID: 20697298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma.
    Miyamae Y; Shimizu K; Hirato J; Araki T; Tanaka K; Ogawa H; Kakegawa S; Sugano M; Nakano T; Mitani Y; Kaira K; Takeyoshi I
    Oncol Rep; 2011 Apr; 25(4):921-8. PubMed ID: 21318227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
    Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
    J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].
    Han Y; Xu JM; Duan HQ; Zhang Y; Liu XQ; Zhang JS
    Chin J Cancer; 2010 Jan; 29(1):69-75. PubMed ID: 20038315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.
    Zhang Y; Yang H; Qiu Y; Deng Q; Liu J; Zhao M; He P; Mo M; Zou X; He J
    Med Oncol; 2014 Mar; 31(3):803. PubMed ID: 24452282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.
    Stabile LP; Dacic S; Land SR; Lenzner DE; Dhir R; Acquafondata M; Landreneau RJ; Grandis JR; Siegfried JM
    Clin Cancer Res; 2011 Jan; 17(1):154-64. PubMed ID: 21062926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue.
    Fasco MJ; Hurteau GJ; Spivack SD
    Mol Cell Endocrinol; 2002 Feb; 188(1-2):125-40. PubMed ID: 11911952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification.
    Zhong L; Zhang C; Jia W; Zhang P
    Ann Diagn Pathol; 2021 Apr; 51():151700. PubMed ID: 33465722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
    Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
    BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
    Raso MG; Behrens C; Herynk MH; Liu S; Prudkin L; Ozburn NC; Woods DM; Tang X; Mehran RJ; Moran C; Lee JJ; Wistuba II
    Clin Cancer Res; 2009 Sep; 15(17):5359-68. PubMed ID: 19706809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
    Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
    Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.
    Bell DW; Brannigan BW; Matsuo K; Finkelstein DM; Sordella R; Settleman J; Mitsudomi T; Haber DA
    Clin Cancer Res; 2008 Jul; 14(13):4079-84. PubMed ID: 18593984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of lung cancer in women: importance of hormonal and growth factors.
    Rouquette I; Lauwers-Cances V; Allera C; Brouchet L; Milia J; Nicaise Y; Laurent J; Delisle MB; Favre G; Didier A; Mazières J
    Lung Cancer; 2012 Jun; 76(3):280-5. PubMed ID: 22197614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study.
    Schneider CP; Heigener D; Schott-von-Römer K; Gütz S; Laack E; Digel W; Guschall WR; Franke A; Bodenstein H; Schmidtgen C; Reck M
    J Thorac Oncol; 2008 Dec; 3(12):1446-53. PubMed ID: 19057271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.